Post-marketing hospital centralized monitoring of clinical safety of Shuganning injectio
Phase 4
Recruiting
- Conditions
- Adverse drug reactions
- Registration Number
- ITMCTR2100004833
- Lead Sponsor
- The First Affiliated Hospital of Henan University of Chinese Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
1.During the monitoring period, all inpatients receiving Shuganning injection were observed;
2.The same patient with different times of medication, the interval between two times of medication is less than 3 days (<= 3 days), which is regarded as one observation object. More than 3 days (> 3 days), according to the new observation object.
Exclusion Criteria
Inpatients who are unable to collect the information needed for this study.
Study & Design
- Study Type
- Observational study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ADR/ADE;
- Secondary Outcome Measures
Name Time Method